MONZA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.391
EU - Europa 2.851
AS - Asia 1.361
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
SA - Sud America 2
Totale 9.619
Nazione #
US - Stati Uniti d'America 5.317
IT - Italia 738
DE - Germania 598
CN - Cina 565
SE - Svezia 446
SG - Singapore 387
IE - Irlanda 313
RU - Federazione Russa 232
GB - Regno Unito 159
HK - Hong Kong 117
VN - Vietnam 115
UA - Ucraina 93
CA - Canada 72
DK - Danimarca 68
IN - India 65
FR - Francia 55
TR - Turchia 44
FI - Finlandia 39
AT - Austria 29
ID - Indonesia 22
BE - Belgio 20
JP - Giappone 18
NL - Olanda 14
KR - Corea 12
CZ - Repubblica Ceca 9
ES - Italia 7
IR - Iran 7
HR - Croazia 6
AU - Australia 5
EU - Europa 5
RO - Romania 5
PT - Portogallo 4
RS - Serbia 4
BG - Bulgaria 3
CH - Svizzera 3
PL - Polonia 3
SC - Seychelles 3
GT - Guatemala 2
TW - Taiwan 2
AM - Armenia 1
BR - Brasile 1
CL - Cile 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
Totale 9.619
Città #
Ann Arbor 1.890
Frankfurt am Main 456
Wilmington 367
Chandler 358
Singapore 322
Woodbridge 314
Milan 305
Dublin 303
Dearborn 246
Ashburn 214
Fairfield 213
Houston 180
New York 176
Princeton 140
Hong Kong 114
Nanjing 114
Jacksonville 104
Seattle 93
Boardman 90
Santa Clara 69
Cambridge 65
Shanghai 62
Guangzhou 57
Dong Ket 49
Nanchang 38
Lawrence 33
Altamura 32
Pune 29
Shenyang 29
Vienna 29
Hangzhou 27
Toronto 22
Beijing 21
Los Angeles 21
Shangdi 21
Ottawa 20
Zhengzhou 20
Andover 19
Fremont 19
Kunming 19
Carate Brianza 18
Helsinki 18
Jakarta 18
San Diego 18
Brussels 17
Dallas 17
Kocaeli 17
Sacramento 16
Falls Church 15
Rome 15
Tianjin 15
Jiaxing 14
Jinan 14
Edmonton 13
Hebei 13
Lachine 13
Changsha 12
Lissone 12
Mainz 12
Norwalk 12
Codroipo 10
London 10
Florence 9
Kiev 9
Sesto San Giovanni 8
Canazei 7
Hefei 7
Wuhan 7
Frederick 6
Grafing 6
Induno Olona 6
Melzo 6
Taizhou 6
Tokyo 6
Brno 5
Cagliari 5
Chandigarh 5
Chengdu 5
Council Bluffs 5
Falkenstein 5
Lanzhou 5
Merate 5
Ningbo 5
Paderno Dugnano 5
Pavia 5
Villeurbanne 5
Washington 5
Zagreb 5
Bologna 4
Cislago 4
Duncan 4
Haikou 4
Lappeenranta 4
Laurel 4
Leawood 4
Lyon 4
Mumbai 4
Perugia 4
San Mateo 4
Tacoma 4
Totale 7.220
Nome #
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 294
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 291
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 223
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 217
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 216
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 211
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 208
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 198
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 198
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 197
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 197
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 193
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 190
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 187
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 181
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 181
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 180
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 178
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 173
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 171
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 170
In vitro models for studying oxaliplatin neurotoxic effects 165
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 164
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 163
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 161
Incubation with low doses of oxaliplatin modifies the electrophysiological properties of dorsal root ganglion neurons 157
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 148
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 147
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 145
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 145
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 144
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 140
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 139
Thermal plantar test in experimental ischemic stroke 134
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 134
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 132
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 129
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 127
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 126
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 125
Multimodal experimental approach to the study of human neurological diseases 124
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 122
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 121
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 121
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 121
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 120
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 120
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 113
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 113
Pharmacokinetics of IVIg in Wistar rats 111
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 105
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 104
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 103
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 98
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 96
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 95
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 93
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 93
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 93
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 90
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 90
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 90
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 89
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 88
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 81
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 79
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 79
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 73
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 72
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 65
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 64
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 60
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 58
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 53
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 46
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 42
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 39
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 32
A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain 19
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 17
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 13
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 11
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 10
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 9
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 9
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 8
Totale 10.431
Categoria #
all - tutte 33.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.293 0 0 100 105 132 216 239 106 117 148 110 20
2020/20212.161 48 59 222 210 155 226 249 254 179 160 161 238
2021/20221.207 122 164 133 116 84 96 60 54 49 63 84 182
2022/20231.828 198 362 223 187 155 304 58 84 120 31 64 42
2023/20241.293 56 46 59 76 144 292 191 75 63 32 40 219
2024/2025795 163 470 162 0 0 0 0 0 0 0 0 0
Totale 10.431